Trimi vs TMates: Semaglutide Pricing, Access, and Support
Trimi vs TMates: both offer compounded semaglutide delivered by telehealth, but they differ most on price, clinician access, tirzepatide availability, shipping, and refund policies. Early verdict: choose Trimi if low flat price and free overnight shipping matter; choose TMates if 24/7 U.S. doctor access and a clinician-focused model are your priority.
Direct comparison: price, access, and medication options
Below I compare the most distinctive differences using only the supplied facts: Trimi lists compounded semaglutide from $99/mo on an annual plan and tirzepatide at $125/month, with flat pricing that never rises as dose increases and free overnight, temperature-controlled shipping. TMates lists semaglutide at $199/month flat, offers 24/7 U.S. doctor access across all 50 states, and provides free shipping and virtual check-ins. Both note that compounded medications are not FDA-approved.
Comparison table at a glance
| Criteria | Trimi | TMates |
|---|---|---|
| Starting price | Compounded semaglutide from $99/mo on the annual plan; tirzepatide $125/month | $199/month flat for semaglutide |
| Price model | Flat pricing that never rises as dose increases; same price at every dose | Flat $199/month at every dose, no step-up fees |
| Clinician access | Prescribed by US-licensed clinicians through Arora Health network | 24/7 access to U.S.-based doctors; virtual check-ins included |
| Medication options | Compounded semaglutide and compounded tirzepatide offered | Compounded semaglutide emphasized; tirzepatide availability less detailed |
| Shipping and fulfillment | Free overnight, temperature-controlled shipping; state-licensed 503A pharmacies named | Free shipping; meds formulated in U.S.-based facilities |
| Refunds and guarantees | 6-month money-back promise; not approved by medical team = 100% automatic refund | Cancel anytime; no specific money-back promise captured |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Price and membership structure compared
Trimi’s headline price is compounded semaglutide from $99/mo on an annual plan and tirzepatide at $125/month, with repeated emphasis that all doses carry the same flat price and that your price never changes as dose is adjusted. TMates presents a flat $199/month rate for compounded semaglutide, also the same price at every dose and marketed as no step-up fees. If raw monthly cost is the deciding factor, Trimi is presented as the lower-cost option; if steady flat pricing with broader clinician access is the priority, TMates presents a clinician-focused flat model.
View TMates semaglutide program
Clinician access and medical oversight
Trimi’s clinical oversight is delivered by licensed U.S. clinicians through Arora Health, led by a named medical director, and the site emphasizes named compounding pharmacies with certificates of analysis available on request. TMates highlights 24/7 access to U.S.-based doctors across all 50 states and virtual check-ins for ongoing medical oversight. The supplied facts show Trimi emphasizes named clinical network and pharmacy transparency while TMates emphasizes round-the-clock physician availability.
Medication options and compounding details
Trimi explicitly offers compounded tirzepatide and compounded semaglutide. TMates focuses on compounded semaglutide, with less public detail on tirzepatide availability in the captured evidence. Both providers are explicit that compounded medications are not FDA-approved; Trimi repeats that compounded medications are prepared per individual prescription and are not themselves FDA-approved as drugs.
Explore Trimi tirzepatide and semaglutide
Shipping, refunds, and practical terms
Trimi advertises free overnight, temperature-controlled shipping and a 6-month money-back promise with an automatic refund if not approved by their medical team. TMates advertises free shipping and a cancel-anytime policy; the evidence captured does not supply a comparable money-back promise. Both note availability depends on medical eligibility and state coverage may vary.
Check Trimi eligibility and shipping
Final comparison and how to choose
Trimi vs TMates centers on cost versus continuous clinical access. Trimi: lower advertised starting cost (compounded semaglutide from $99/mo and tirzepatide $125/month), named compounding pharmacies, free overnight shipping, and a 6-month money-back promise. TMates: flat $199/month for semaglutide, 24/7 U.S. doctor access across all 50 states, and virtual check-ins. Both use compounded medications and note they are not FDA-approved.
Choose Trimi if you prioritize lower flat pricing, free overnight temperature-controlled shipping, named compounding pharmacies, and the 6-month money-back promise.
Choose TMates if you prioritize 24/7 access to U.S.-based doctors, a clinician-focused virtual check-in model, and a straightforward flat $199/month semaglutide program.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →